• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复杂型消化性溃疡病的流行病学:发病率、复发率、危险因素和死亡率的系统评价。

Systematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortality.

机构信息

Department of Surgery, Chinese University of Hong Kong, Hong Kong, SAR, China.

出版信息

Digestion. 2011;84(2):102-13. doi: 10.1159/000323958. Epub 2011 Apr 14.

DOI:10.1159/000323958
PMID:21494041
Abstract

BACKGROUND/AIMS: The incidence of uncomplicated peptic ulcer has decreased in recent years. It is unclear what the impact of this has been on the epidemiology of peptic ulcer complications. This systematic review aimed to determine the incidence, recurrence and mortality of complicated peptic ulcer and the risk factors associated with these events.

METHODS

Systematic PubMed searches.

RESULTS

Overall, 93 studies were identified. Annual incidence estimates of peptic ulcer hemorrhage and perforation were 19.4-57.0 and 3.8-14 per 100,000 individuals, respectively. The average 7-day recurrence of hemorrhage was 13.9% (95% CI: 8.4-19.4), and the average long-term recurrence of perforation was 12.2% (95% CI: 2.5-21.9). Risk factors for peptic ulcer complications and their recurrence included nonsteroidal anti-inflammatory drug and/or acetylsalicylic acid use, Helicobacter pylori infection and ulcer size ≥1 cm. Proton pump inhibitor use reduced the risk of peptic ulcer hemorrhage. Average 30-day mortality was 8.6% (95% CI: 5.8-11.4) after hemorrhage and 23.5% (95% CI: 15.5-31.0) after perforation. Older age, comorbidity, shock and delayed treatment were associated with increased mortality.

CONCLUSIONS

Complicated peptic ulcer remains a substantial healthcare problem which places patients at a high risk of recurrent complications and death.

摘要

背景/目的:近年来,无并发症消化性溃疡的发病率有所下降。目前尚不清楚这对消化性溃疡并发症的流行病学有何影响。本系统综述旨在确定复杂消化性溃疡的发生率、复发率和死亡率,以及与这些事件相关的危险因素。

方法

系统地进行了 PubMed 检索。

结果

共确定了 93 项研究。消化性溃疡出血和穿孔的年发生率估计分别为 19.4-57.0 和 3.8-14/10 万人。出血的 7 天平均复发率为 13.9%(95%CI:8.4-19.4),穿孔的长期平均复发率为 12.2%(95%CI:2.5-21.9)。消化性溃疡并发症及其复发的危险因素包括非甾体抗炎药和/或乙酰水杨酸的使用、幽门螺杆菌感染和溃疡直径≥1cm。质子泵抑制剂的使用降低了消化性溃疡出血的风险。出血后 30 天的平均死亡率为 8.6%(95%CI:5.8-11.4),穿孔后为 23.5%(95%CI:15.5-31.0)。年龄较大、合并症、休克和延迟治疗与死亡率增加相关。

结论

复杂消化性溃疡仍然是一个严重的医疗保健问题,使患者面临反复发生并发症和死亡的高风险。

相似文献

1
Systematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortality.复杂型消化性溃疡病的流行病学:发病率、复发率、危险因素和死亡率的系统评价。
Digestion. 2011;84(2):102-13. doi: 10.1159/000323958. Epub 2011 Apr 14.
2
H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer.幽门螺杆菌根除疗法与抗分泌非根除疗法(无论是否联合长期维持抗分泌疗法)用于预防消化性溃疡复发性出血的比较
Cochrane Database Syst Rev. 2003(4):CD004062. doi: 10.1002/14651858.CD004062.
3
H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer.幽门螺杆菌根除疗法与抗分泌非根除疗法(无论是否联合长期维持抗分泌疗法)用于预防消化性溃疡复发性出血的比较
Cochrane Database Syst Rev. 2004(2):CD004062. doi: 10.1002/14651858.CD004062.pub2.
4
Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people.幽门螺杆菌阳性人群消化性溃疡疾病的根除治疗。
Cochrane Database Syst Rev. 2016 Apr 19;4(4):CD003840. doi: 10.1002/14651858.CD003840.pub5.
5
Does Seasonality Affect Peptic Ulcer Perforation? A Single-Center Retrospective Study.季节因素会影响消化性溃疡穿孔吗?一项单中心回顾性研究。
Medicina (Kaunas). 2025 May 22;61(6):945. doi: 10.3390/medicina61060945.
6
Medical versus surgical treatment for refractory or recurrent peptic ulcer.难治性或复发性消化性溃疡的内科治疗与外科治疗
Cochrane Database Syst Rev. 2016 Mar 29;3(3):CD011523. doi: 10.1002/14651858.CD011523.pub2.
7
Evaluation and management of patients with recurrent peptic ulcer disease after acid-reducing operations: a systematic review.抑酸手术后复发性消化性溃疡病患者的评估与管理:一项系统评价
J Gastrointest Surg. 2003 Jul-Aug;7(5):606-26. doi: 10.1016/s1091-255x(02)00034-3.
8
Perforated peptic ulcer: how to improve outcome?穿孔性消化性溃疡:如何改善预后?
Scand J Gastroenterol. 2009;44(1):15-22. doi: 10.1080/00365520802307997.
9
Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s.非甾体抗炎药与上消化道出血/穿孔之间的关联:20世纪90年代发表的流行病学研究综述。
Arch Intern Med. 2000 Jul 24;160(14):2093-9. doi: 10.1001/archinte.160.14.2093.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

引用本文的文献

1
Exploration of the mechanism of Danggui Buxue decoction for the treatment of gastric ulcer based on network pharmacology, molecular docking, and experiment.基于网络药理学、分子对接和实验探索当归补血汤治疗胃溃疡的机制
J Tradit Chin Med. 2025 Aug;45(4):806-816. doi: 10.19852/j.cnki.jtcm.20250318.002.
2
One-Stage Versus Two-Stage Gastrectomy for Perforated Gastric Cancer: Systematic Review and Meta-Analysis.一期与二期胃切除术治疗穿孔性胃癌:系统评价与Meta分析
J Clin Med. 2025 Jun 29;14(13):4603. doi: 10.3390/jcm14134603.
3
fruit extract antiulcerogenic effect: comparative study with lansoprazole and ranitidine in rats.
水果提取物的抗溃疡作用:与兰索拉唑和雷尼替丁在大鼠中的比较研究。
Front Med (Lausanne). 2025 Jun 25;12:1544422. doi: 10.3389/fmed.2025.1544422. eCollection 2025.
4
Perforated Peptic Ulcer in Lagos. Risk Factors and Management Outcome.拉各斯的消化性溃疡穿孔。危险因素及治疗结果
J West Afr Coll Surg. 2025 Jul-Sep;15(3):258-264. doi: 10.4103/jwas.jwas_46_24. Epub 2024 Sep 2.
5
Nonsteroidal Anti-Inflammatory Drug-Induced Peptic Ulcer Disease.非甾体抗炎药引起的消化性溃疡病
Korean J Helicobacter Up Gastrointest Res. 2025 Mar;25(1):34-41. doi: 10.7704/kjhugr.2025.0004. Epub 2025 Mar 7.
6
Laparoscopic surgery in acute perforated gastroduodenal ulcers: an underutilized technique despite favorable short-term outcomes.腹腔镜手术治疗急性胃十二指肠溃疡穿孔:尽管短期疗效良好,但该技术未得到充分利用。
Surg Endosc. 2025 May 27. doi: 10.1007/s00464-025-11855-6.
7
A global perspective on smoking's impact on peptic ulcer disease: DALY trends and projections.吸烟对消化性溃疡疾病影响的全球视角:伤残调整生命年趋势与预测
Front Public Health. 2025 Apr 29;13:1550045. doi: 10.3389/fpubh.2025.1550045. eCollection 2025.
8
Perforated peptic ulcers in children: a systematic review.儿童消化性溃疡穿孔:一项系统评价
BMC Pediatr. 2025 May 7;25(1):363. doi: 10.1186/s12887-025-05725-2.
9
Prevalence and patterns of peptic ulcer disease in Africa: a systematic review and meta-analysis.非洲消化性溃疡疾病的患病率及模式:一项系统评价与荟萃分析
BMC Gastroenterol. 2025 Apr 25;25(1):298. doi: 10.1186/s12876-025-03906-y.
10
Non-epinephrine monotherapy matches combination therapy in high-risk PUB patients.非肾上腺素单一疗法在高危消化性溃疡出血患者中与联合疗法效果相当。
Sci Rep. 2025 Apr 14;15(1):12763. doi: 10.1038/s41598-025-97705-w.